David J. Wustrow
Corporate Officer/Principal chez RAPT THERAPEUTICS, INC.
Profil
David J.
Wustrow is currently the Senior VP-Drug Discovery & Preclinical Development at Rapt Therapeutics, Inc. He previously held positions as the Executive Director-Chemistry at Neurogen Corp., Senior Director-Neuroscience Chemistry at Pfizer Inc., Executive Director-Scientific Assessment at XenoPort, Inc., Senior Director-Neuroscience Chemistry at Pfizer NV, Executive Director-Chemistry at Neurogen Technologies, Inc., and VP-Chemistry & Pharmaceutical Sciences at Cleave Therapeutics, Inc. Dr. Wustrow holds a doctorate degree from Rochester Christian University and an undergraduate degree from The Pennsylvania State University.
Postes actifs de David J. Wustrow
| Sociétés | Poste | Début |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de David J. Wustrow
| Sociétés | Poste | Fin |
|---|---|---|
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/02/2016 |
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2012 |
| Neurogen Technologies, Inc. | Corporate Officer/Principal | 01/01/2008 |
| Pfizer NV/SA | Corporate Officer/Principal | 01/10/2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2005 |
Formation de David J. Wustrow
| Rochester Christian University | Doctorate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
| Pfizer NV/SA | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
| Neurogen Technologies, Inc. |
